Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
Research output: Contribution to journal › Journal article › peer-review
Documents
- 1878-0261.12660
Final published version, 341 KB, PDF document
Original language | English |
---|---|
Journal | Molecular Oncology |
Volume | 14 |
Issue number | 5 |
Pages (from-to) | 964-973 |
ISSN | 1574-7891 |
DOIs | |
Publication status | Published - 2020 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 238743138